Yes they are hilarious, but no less maddening. I still just cannot wrap my head around how CTIX can put out the best possible news, say like MEETING THE PRIMARY ENDPOINT in a drug trial, and have people who will sell their shares. Just totally nonsensical to me.

Good thing the scientists and big pharma folks are not stupid. They are going to see that P outperformed Anacor Pharmaceuticals' topical anti-inflammatory compound, successfully treated patients who were previously unsuccessfully treated with other therapies (biologics and apremilast (Otezla®)), and that P will be a direct competitor in the moderate/severe psoriasis market.

IMO Leo is going to have partners and buyers at his door very soon.